HOME >> BIOLOGY >> NEWS
Research team enlightens the reasons for severe blindness

People suffering from a severe retinal disease will sooner or later lose their eyesight considerably or even become completely blind. Those affected, family members, researchers and doctors hope that this fate might be avoided one day by a better understanding of the reasons for this disease. Coordinated by the geneticist Ronald Roepman from Nijemegen, an important step has now been made in this direction by an international research team with the participation of the GSF - National Research Center for Environment and Health: they identified a further gene for the inherited retinal disease Leber Congenital Amaurosis (LCA) and discovered first evidences how it functions. This represents new opportunities for gene therapy, which especially for LCA, is considered as very promising since the disease is caused by a single mutation.

LCA causes blindness very early on often shortly after or within a few months of birth. The disease can be caused through a single mutation in different genes; with the newly discovered LCA5 gene, ten disease-causing genes had been identified so far which are responsible for approx. 60 % of all LCA diseases. All these deficiencies lead in the end to the same symptoms, however, in order to treat the disease efficiently with the individual patient, it is important to know which gene mutation occurred in the specific case and what it causes, underlines Dr. Marius Ueffing (GSF Institute for Human Genetics), who leads the project at GSF.

The LCA5 gene encodes the lebercilin, a so far unknown protein. Through proteomic methods, Ueffings team could demonstrate that lebercilin specifically interacts with other proteins which play a role in the protein transport in the cells. Thus the scientists concluded that lebercilin is relevant for the protein transport within the optical cell: as shown by electro-microscopic pictures, within the optical cell described as the photoreceptor, lebercilin binds the most to the so-called cilium,
'"/>

Contact: Heinz-Joerg Haury
haury@gsf.de
49-893-187-2460
GSF - National Research Center for Environment and Health
6-Aug-2007


Page: 1 2 3

Related biology news :

1. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
2. Research shows skeleton to be endocrine organ
3. Research aims to identify markers for menopausal women at risk for deadly blood clot
4. Research teams uncover risk genes for multiple sclerosis
5. Research shows NPD1 protects a key component of vision
6. Researchers find pathway that controls cell size and division
7. Researchers watch antibiotics, bacteria meet at atomic level
8. Researchers discover gene responsible for Restless Legs Syndrome
9. Research study describes the role part of the brain plays in memory
10. NY Stem Cell Foundations 2nd Annual Translational Stem Cell Research Conference
11. Researchers witness natural selection at work in dramatic comeback of male butterflies

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Research team enlightens the reasons for severe blindness

(Date:5/23/2013)... Bochum,s medics have succeeded in treating cerebral palsy with ... brain damage, a 2.5 year old boy had been ... of survival. Just two months after treatment with the ... over the following months, the child learned to speak ... those from a Korean study, dispel the long-held doubts ...
(Date:5/23/2013)... Neuron , the team reveal the interplay of ... funded by the Wellcome Trust and BBSRC. , ... we improve our perceptual abilities. While these changes can ... also affect the fidelity of that response. ... explains: "When you communicate with others, you can make ...
(Date:5/22/2013)... conclude that the 20 percent reduction in lung ... chest X-ray (CXR) screening previously reported in the ... centers in the United States. , Philadelphia, PAPhysicians ... about the benefits and risks of LDCT lung ... New England Journal of Medicine of the ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3
(Date:5/23/2013)... Korea , May 23, 2013 ... SillaJen, Inc., a private biotherapeutics and contract research ... biological products for cancer, announced today a publication ... patients treated with the oncolytic and immunotherapeutic vaccinia ... This research was published in the May 15 ...
(Date:5/23/2013)... Bed bugs compromised Penn State. A ... it. Meanwhile, My Cleaning Products offered complimentary samples of its ... pests without using harmful chemical elements. , Based on ... affected building was actually a dormitory , My Cleaning ... on May 13 and bed bug presence was confirmed on ...
(Date:5/22/2013)... PA (PRWEB) May 22, 2013 Oven ... with the integrated potentiometers or via a PC ... design measuring two and one half inches square can ... a zero voltage switched, low noise solid state relay. ... power isolation for the communication port and sensor input. ...
(Date:5/22/2013)... The Conference Forum announced the launch ... Trials conference taking place on September 19-20 at the ... Disruptive thinkers from Novartis, Pfizer, Eli Lilly, Shire, Medimmune, ... reduce expensive infrastructure, engage patients and generate credible clinical ... or novel, or it must change the very nature ...
Breaking Biology Technology:Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2New AC Temperature Controller Announced by Oven Industries 2Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2
Cached News: